Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Sinobiopharma’s Flagship Product OK’d for Insurance Coverage

publication date: Feb 2, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Sinobiopharma, Inc. reported its most important product, the skeletal muscle relaxant KuTai (Cisatracurium Besylate), is now covered by China’s major insurance plan, the National Basic Medical Insurance, Employment Injury Insurance and Maternity Insurance (2009 Edition). The company recently reported that KuTai accounts for 96% of its revenues. More details...

Stock Symbol: (OTCBB: SNBP)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...